In inflammation-prone animal models, IL-6, as one of myokines, showed a beneficial effect in the development of NAFLD by downregulating lipogenic genes and upregulating fatty acid oxidation-associated genes [55]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.